Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer

Gastroenterology

Volumn 151, Issue 3, 2016, Pages 472-480.e1

  Chang, Mei Hwei ^a   You, San Lin ^b   Chen, Chien Jen ^c   Liu, Chun Jen ^a   Lai, Ming Wei ^d   Wu, Tzee Chung ^e   Wu, Shu Fen ^f   Lee, Chuan Mo ^g   Yang, Sheng Shun ^e   Chu, Heng Cheng ^h   Wang, Tsang Eng ⁱ   Chen, Bor Wen ^j   Chuang, Wan Long ^k   Soon, Maw Soan ^l   Lin, Ching Yih ^m   Chiou, Shu Ti ^e   Kuo, Hsu Sung ⁿ   Chen, Ding Shinn ^a,c   Yang, Yao Jong ^o   Lo, Gin Ho ^o   Kong, Man San ^o   Wang, Po Ming ^o   Yang, Chi Chieh ^o   Chu, Chia Hsiang ^o   Lin, Lung Huan ^o   Chien, Rong Nan ^o   Lee, Tzong Hsi ^o   Yang, Kuo Ching ^o   Liao, Li Ying ^o   Mo, Lein Ray ^o   Liu, Jean Dean ^o   Yang, Tzeng Huey ^o   Lo, Ching Chu ^o   Tsai, Ming Hung ^o   Chou, Chang Hua ^o   Cheng, Yeong Shan ^o   more..

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c ACADEMIA SINICA   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^h TRI SERVICE GENERAL HOSPITAL   (Taiwan)

ⁱ MACKAY MEMORIAL HOSPITAL   (Taiwan)

^j KOO FOUNDATION SUN YAT SEN CANCER CENTER   (Taiwan)

^k KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^l CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^m CHI MEI MEDICAL CENTER   (Taiwan)

ⁿ CENTER FOR DISEASE CONTROL   (Taiwan)

^o Health Promotion Administration ^*

more..

Author keywords

Cancer Prevention; Liver Carcinogenesis; Population Study; Viral Hepatitis

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; RECOMBINANT VACCINE;

ADOLESCENT; ADULT; AGE; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOTHER; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; TAIWAN; VACCINATION; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; CARCINOMA, HEPATOCELLULAR; INCIDENCE; LIVER NEOPLASMS; PROCEDURES; REGISTER; REGRESSION ANALYSIS; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TIME; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CARCINOMA, HEPATOCELLULAR; CHILD; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; REGISTRIES; REGRESSION ANALYSIS; RISK FACTORS; TAIWAN; TIME; VACCINATION; YOUNG ADULT;

EID: 84979702245     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.05.048     Document Type: Article

References (31)

1. 1 International Agency for research on Cancer, World Health Organization. GLOBOCAN: estimated cancer incidence, mortality and prevalence worldwide in 2012. www.globocan.iarc.fr/. Accessed June 27, 2015.
2. 2 Beasley, R.P., Hepatitis B virus as the etiologic agent in hepatocellular carcinoma; epidemiologic considerations. Hepatology 2:Suppl (1982), 21–26.
3. 3 Chang, M.H., Chen, C.J., Lai, M.S., et al. Universal hepatitis B vaccination in Taiwan and the childhood hepatocellular carcinoma in children. N Engl J Med 336 (1997), 1855–1859.
4. 4 Chang, M.H., You, S.L., Chen, C.J., et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 101 (2009), 1348–1355.
5. 5 McMahon, B.J., Bulkow, L.R., Singleton, R.J., et al. Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program. Hepatology 54 (2011), 801–807.
6. 6 Wichajarn, K., Kosalaraksa, P., Wiangnon, S., Incidence of hepatocellular carcinoma in children in Khon Kaen before and after national hepatitis B vaccine program. Asian Pac J Cancer Prev 9 (2008), 507–509.
7. 7 Center, M.M., Jemal, A., International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev 20 (2011), 2362–2368.
8. 8 Lu, C.Y., Ni, Y.H., Chiang, B.L., et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis 15;197 (2008), 1419–1426.
9. 9 McMahon, B.J., Dentinger, C.M., Bruden, D., et al. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis 200 (2009), 1390–1396.
10. 10 Ni, Y.H., Chang, M.H., Wu, J.F., et al. Minimization of hepatitis B infection by a 25-year universal vaccination program. J Hepatol 57 (2012), 730–735.
11. 11 Beasley, R.P., Rocks along the road to the control of HBV and HCC. Ann Epidemiol 19 (2009), 231–234.
12. 12 Chen, C.N., Liu, P.K.C., An evaluation of Taiwan Census 2000: a comparison of census and registered populations. J Popul Stud 25 (2002), 1–56.
13. 13 Kuo, C.Y., Liu, H.C., Chang, M.H., et al. Hepatoblastoma in infancy and childhood: a clinical and pathological study of 32 cases. Acta Paediatr Taiwan 32 (1991), 79–87.
14. 14 Chiang, C.J., Chen, Y.C., Chen, C.J., et al. Cancer trends in Taiwan. Jpn J Clin Oncol 10 (2010), 897–904.
15. 15 Chen, D.S., Hsu, N.H., Sung, J.L., et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen carrier mothers. JAMA 257 (1987), 2597–2603.
16. 16 Feinstein, A.R., Principles of Medical Statistics. 2001, CRC Press, New York.
17. 17 Munoz, N., Bosch, X., Epidemiology of hepatocellular carcinoma. Okuda, K., Ishak, K.G., (eds.) Neoplasms of the Liver, 1987, Springer-Verlag, Tokyo, 3–19.
18. 18 Marquardt, J.U., Andersen, J.B., Thorgeirsson, S.S., Functional and genetic deconstruction of the cellular origin in liver cancer. Nat Rev Cancer 15 (2015), 653–667.
19. 19 Hoshida, Y., Villanueva, A., Kobayashi, M., et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 359 (2008), 1995–2004.
20. 20 Chen, C.L., Yang, H.I., Yang, W.S., et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 135 (2008), 111–121.
21. 21 Hsieh, H.I., Chen, P.C., Wong, R.H., et al. Mortality from liver cancer and leukaemia among polyvinyl chloride workers in Taiwan: an updated study. Occup Environ Med 68 (2011), 120–125.
22. 22 Hassan, M.M., Abdel-Wahab, R., Kaseb, A., et al. Obesity early in adulthood increases risk but does not affect outcomes of hepatocellular carcinoma. Gastroenterology 149 (2015), 119–129.
23. 23 Stevens, C.E., Toy, P.T., Talor, P.E., et al. Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection. Pediatrics 90 (1992), 170–173.
24. 24 Centers for Disease Control. Recommendations of the Immunization Practices Advisory Committee update on hepatitis B prevention. JAMA 258 (1987), 437–449.
25. 25 Lai, C.L., Wong, B.C.Y., Yeoh, E.K., et al. Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma- derived vaccine in children: immunogenicity and anamnestic responses. Hepatology 18 (1993), 763–767.
26. 26 Ni, Y.H., Chang, M.H., Huang, L.M., et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 135 (2001), 796–800.
27. 27 Chang, M.H., Chen, T.H., Hsu, H.M., et al. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. Clin Cancer Res 11 (2005), 7953–7957.
28. 28 Wen, W.H., Chang, M.H., Zhao, L.L., et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J Hepatol 59 (2013), 24–30.
29. 29 Chen, H.L., Lin, L.H., Hu, F.C., et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 142 (2012), 773–781.
30. 30 Chen, H.L., Lee, C.N., Chang, C.H., et al. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology 62 (2015), 375–386.
31. 31 Chang, M.H., Shau, W.Y., Chen, C.J., et al., Taiwan Childhood Hepatoma Study Group. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA 284 (2000), 3040–3042.